Home › Funds › BlackRock Inc › SRPT
BlackRock Inc position in SRPT
SAREPTA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)18.99M sh
Reported value held$341.34M
Portfolio Weight0.01%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 9.40M | $10.65M | New |
| Q4 2024 | 11.82M | $12.98M | Add |
| Q1 2025 | 11.93M | $11.07M | Add |
| Q2 2025 | 11.43M | $8.23M | Reduce |
| Q3 2025 | 4.08M | $3.58M | Reduce |
| Q4 2025 | 14.28M | $307.38M | Add |
| Q1 2026 | 14.76M | $321.07M | Add |
| Q2 2026 | 18.99M | $341.34M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SRPT
- Vanguard Group 11.81M sh · $254.17M · Q4 2025
- Two Sigma Investments 4.60M sh · $82.64M · Q2 2026
- AQR Capital Management 4.33M sh · $76.87M · Q2 2026
- Geode Capital Management 2.77M sh · $49.82M · Q2 2026
- Marshall Wace 2.21M sh · $39.64M · Q2 2026
- Morgan Stanley 2.20M sh · $39.58M · Q2 2026
- Bank of America Corp 2.06M sh · $36.95M · Q2 2026
- Goldman Sachs Group 2.04M sh · $36.70M · Q2 2026
- Citadel Advisors 1.54M sh · $27.75M · Q2 2026
- Northern Trust Corp 1.21M sh · $21.76M · Q2 2026
- Millennium Management 1.19M sh · $21.45M · Q2 2026